{"id":11452,"date":"2025-03-14T14:00:02","date_gmt":"2025-03-14T14:00:02","guid":{"rendered":"https:\/\/www.caltagmedsystems.co.uk\/information\/?p=11452"},"modified":"2025-03-18T15:54:35","modified_gmt":"2025-03-18T15:54:35","slug":"mhc-monomer-tetramer-product-validation-data","status":"publish","type":"post","link":"https:\/\/www.caltagmedsystems.co.uk\/information\/mhc-monomer-tetramer-product-validation-data\/","title":{"rendered":"KACTUS: MHC Monomer &amp; Tetramer Product Validation Data"},"content":{"rendered":"\n<p>KACTUS has demonstrated, via ELISA and SPR binding assays, that their MHC-peptide complexes and  loaded peptide-ready MHCs have good binding affinity to TCRs. Their MHC products are well-suited for applications such as antibody binding, affinity research, TCR screening, and blocking assays.<\/p>\n\n\n\n<div class=\"wp-block-group is-layout-grid wp-container-core-group-is-layout-b757edec wp-block-group-is-layout-grid\">\n<figure class=\"wp-block-image is-resized wp-container-content-5e2576f9\"><img decoding=\"async\" src=\"https:\/\/kactusbio.com\/cdn\/shop\/files\/MHC_ELISA_Fig2.png?v=1721924510&amp;width=1000\" alt=\"MHC ELISA Data Biotinylated HLA-A*02:01 Monomer &amp; SLLMWITQV\" style=\"width:303px;height:auto\"\/><figcaption class=\"wp-element-caption\"><strong>HLA-A*02:01 Tetramer &amp; FMNKIYEI<\/strong><br><br>Figure 1. Immobilized HLA-A*02:01&amp;B2M&amp;AFP (FMNKFIYEI) TCR at 2\u00b5g\/ml (100ul\/well) on the plate can bind\u00a0<a href=\"https:\/\/www.caltagmedsystems.co.uk\/pricing_ordering\/product_detail.php?CI_ID=1790296&amp;group_1=All&amp;group_2=All&amp;supplier=All&amp;clonality=All&amp;host=All&amp;species=All&amp;applications=All&amp;regulatory_status=All&amp;searchwords=MHC-HM407T\">HLA-A*02:01&amp;B2M&amp;AFP (FMNKFIYEI) Tetramer<\/a>, His Tag\u00a0with an EC50 of 26.6ng\/ml determined by ELISA.<\/figcaption><\/figure>\n\n\n\n<figure class=\"wp-block-image is-resized\"><img decoding=\"async\" src=\"https:\/\/kactusbio.com\/cdn\/shop\/files\/MHC_HLA-A_Fig1.png?v=1721924499&amp;width=1000\" alt=\"MHC ELISA Data HLA-A*02:01 Tetramer &amp; FMNKIYEI\" style=\"width:302px;height:auto\"\/><figcaption class=\"wp-element-caption\"><strong>Biotinylated HLA-A*02:01 Monomer &amp; SLLMWITQV<\/strong><br><br>Figure 2. Immobilized Anti-HLA-A*02:01&amp;B2M&amp;NY-ESO-1 (SLLMWITQV) Antibody, hFc Tag at 1ug\/ml (100ul\/well) on the plate. Dose response curve for\u00a0<a href=\"https:\/\/www.caltagmedsystems.co.uk\/pricing_ordering\/product_detail.php?CI_ID=1790266&amp;group_1=All&amp;group_2=All&amp;supplier=All&amp;clonality=All&amp;host=All&amp;species=All&amp;applications=All&amp;regulatory_status=All&amp;searchwords=KAC-MHC-HM40NB\">Biotinylated Human HLA-A*02:01&amp;B2M&amp;NY-ESO-1 (SLLMWITQV) Monomer<\/a>, His Tag with the EC50 of 31.3ng\/ml determined by ELISA.<\/figcaption><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-group is-layout-grid wp-container-core-group-is-layout-b757edec wp-block-group-is-layout-grid\">\n<figure class=\"wp-block-image is-resized\"><img decoding=\"async\" src=\"https:\/\/kactusbio.com\/cdn\/shop\/files\/MHC_SPR_HighAffinity.png?v=1721923959&amp;width=1000\" alt=\"\" style=\"width:303px;height:auto\"\/><figcaption class=\"wp-element-caption\"><strong>HLA-G Tetramer &amp; RIIPRHLQL<\/strong><br>Figure 3. Human LILRB2, hFc Tag captured on CM5 Chip via Protein A can bind\u00a0<a href=\"https:\/\/www.caltagmedsystems.co.uk\/pricing_ordering\/product_detail.php?CI_ID=1791244&amp;group_1=All&amp;group_2=All&amp;supplier=All&amp;clonality=All&amp;host=All&amp;species=All&amp;applications=All&amp;regulatory_status=All&amp;searchwords=KAC-HLG-HM41CT\">Human HLA-G&amp;B2M&amp;Peptide (RIIPRHLQL) Tetramer<\/a>\u00a0with an affinity constant of 4.62 nM as determined in SPR assay (Biacore T200).<\/figcaption><\/figure>\n\n\n\n<figure class=\"wp-block-image is-resized\"><img decoding=\"async\" src=\"https:\/\/kactusbio.com\/cdn\/shop\/files\/MHC_SPR_HighAffinity_1.png?v=1721856260&amp;width=1000\" alt=\"MHC SPR Data High Affinity Binding\" style=\"width:302px;height:auto\"\/><figcaption class=\"wp-element-caption\"><strong>HLA-A*02:01 Tetramer &amp; YLEPGPVTA<\/strong><br>Figure 4. In SPR analysis, the GP100 TCR &amp; Anti-CD3 Bispecific Fusion can bind to the HLA-A*02:01&amp;B2M&amp;GP100 (YLEPGPVTA) complex tetramer, with an affinity constant of 0.196 nM.<\/figcaption><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-group is-layout-grid wp-container-core-group-is-layout-b757edec wp-block-group-is-layout-grid\">\n<figure class=\"wp-block-image is-resized\"><img decoding=\"async\" src=\"https:\/\/kactusbio.com\/cdn\/shop\/files\/MHC_SPR_LowAffinity_Fig2.png?v=1721916202&amp;width=1000\" alt=\"MHC SPR Data on HLA-A*02:01 Monomer &amp; FMNKFIYEI\" style=\"width:305px;height:auto\"\/><figcaption class=\"wp-element-caption\"><strong>HLA-A*02:01 Monomer &amp; FMNKFIYEI<\/strong><br>Figure 5.\u00a0<a href=\"https:\/\/www.caltagmedsystems.co.uk\/pricing_ordering\/product_detail.php?CI_ID=1790291&amp;group_1=All&amp;group_2=All&amp;supplier=All&amp;clonality=All&amp;host=All&amp;species=All&amp;applications=All&amp;regulatory_status=All&amp;searchwords=KAC-MHC-HM407\">Human HLA-A*02:01&amp;B2M&amp;AFP (FMNKFIEl) Monomer<\/a>, His Tag captured on CM5 Chip via Anti-His Antibody can bind HLA-A*02:01&amp;B2M&amp;AFP (FMNKFIYEI) TCR with an affinity constant of 0.3991 \u00b5M as determined in SPR assay (Biacore T200).<\/figcaption><\/figure>\n\n\n\n<figure class=\"wp-block-image is-resized\"><img decoding=\"async\" src=\"https:\/\/kactusbio.com\/cdn\/shop\/files\/MHC_SPR_LowAffinity.png?v=1721923800&amp;width=1000\" alt=\"MHC SPR Data for HLA-A*02:01 Tetramer &amp; FMNKFIYEI\" style=\"width:303px;height:auto\"\/><figcaption class=\"wp-element-caption\"><strong>HLA-A*02:01 Tetramer &amp; FMNKFIYEI<\/strong><br>Figure 6.\u00a0<a href=\"https:\/\/www.caltagmedsystems.co.uk\/pricing_ordering\/product_detail.php?CI_ID=1790296&amp;group_1=All&amp;group_2=All&amp;supplier=All&amp;clonality=All&amp;host=All&amp;species=All&amp;applications=All&amp;regulatory_status=All&amp;searchwords=KAC-MHC-HM407\">Human HLA-A*02:01&amp;B2M&amp;AFP (FMNKFIEl) Tetramer<\/a>, His Tag captured on CM5 Chip via Anti-His Antibody can bind HLA-A*02:01&amp;B2M&amp;AFP (FMNKFIYEI) TCR with an affinity constant of 0.111 \u00b5M as determined in SPR assay (Biacore T200).<\/figcaption><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-group is-layout-grid wp-container-core-group-is-layout-b757edec wp-block-group-is-layout-grid\">\n<figure class=\"wp-block-image is-resized\"><img decoding=\"async\" src=\"https:\/\/kactusbio.com\/cdn\/shop\/files\/MHC_SCT_FACS_6b36a128-cbe9-4984-8562-42b938a25d58.png?v=1723812055&amp;width=1000\" alt=\"MHC single chain trimer FACS analysis\" style=\"width:352px;height:auto\"\/><figcaption class=\"wp-element-caption\"><strong>PE-SA Assembled Tetramer with SIINFEKL, OT1 Mouse Whole Blood<\/strong><br>Figure 7. Flow Cytometry Analysis of OT1 Mouse Whole Blood Cells and T Cells Using PE-SA Assembled Tetramers. The right panel displays the binding of OT1 mouse T cells to the Mouse H-2K(b) &amp; B2M &amp; OVA (SIINFEKL) PE-SA assembled tetramer, with a significant shift in fluorescence and higher percentage of MHC PE-H positive cells (39.60% in Q5-4), compared to the left control, demonstrating effective binding and tetramer assembly.<\/figcaption><\/figure>\n\n\n\n<figure class=\"wp-block-image is-resized\"><img decoding=\"async\" src=\"https:\/\/kactusbio.com\/cdn\/shop\/files\/MHC_SCT_FACS_2_69d48350-e118-414f-98a5-af6b4eeda193.png?v=1723812075&amp;width=1000\" alt=\"MHC single chain trimer FACS analysis\" style=\"width:351px;height:auto\"\/><figcaption class=\"wp-element-caption\"><strong>PE-SA Assembled Tetramer with SIINFEKL, Peptide-Pulsed OT1 Mouse Spleen Blood<\/strong><br>Figure 8. Flow Cytometry Analysis of SIINFEKL Peptide-Pulsed OT1 Mouse Spleen Cells Using PE-SA Assembled Tetramers. The right panel displays the binding of OT1 mouse spleen cells to the custom-assembled tetramer (Mouse H-2K(b) &amp; B2M &amp; OVA (SIINFEKL) PE-SA), with a significant shift in fluorescence and higher percentage of MHC PE-H positive cells (97.41% in Q5-4), demonstrating effective binding and tetramer assembly.<\/figcaption><\/figure>\n<\/div>\n\n\n\n<hr class=\"wp-block-separator has-text-color has-alpha-channel-opacity has-background\" style=\"margin-top:var(--wp--preset--spacing--50);margin-bottom:var(--wp--preset--spacing--50);background-color:#21318f;color:#21318f\"\/>\n\n\n\n<p><a href=\"https:\/\/www.caltagmedsystems.co.uk\/\">Caltag Medsystems\u00a0<\/a>is the distributor of\u00a0KACTUS products in the UK and Ireland. If you have any questions about these products, please\u00a0<a href=\"https:\/\/www.caltagmedsystems.co.uk\/contact.php\">contact us<\/a>.<\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>KACTUS has demonstrated via ELISA &#038; SPR binding assays that their MHC-peptide complexes &#038; loaded peptide-ready MHCs have good binding affinity to TCRs.<\/p>\n","protected":false},"author":13,"featured_media":11448,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,15],"tags":[976,900,978,224],"class_list":["post-11452","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-information","category-tetramer","tag-kactus","tag-monomer","tag-product-validation","tag-tetramer"],"_links":{"self":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts\/11452","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/comments?post=11452"}],"version-history":[{"count":7,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts\/11452\/revisions"}],"predecessor-version":[{"id":11696,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts\/11452\/revisions\/11696"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/media\/11448"}],"wp:attachment":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/media?parent=11452"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/categories?post=11452"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/tags?post=11452"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}